https://www.selleckchem.com/pr....oducts/nsc-23766.htm
Thus, in vitro observations may have a significance in vivo to increase brain sumatriptan levels. Pharmacological inhibition of NHE1 prior to cortical manipulations enhanced the efficacy of sumatriptan at early time-points but induced facial sensitivity alone. Overall, our results suggest that dysregulation of NHE1 contributes to breaches in BBB integrity, drug penetrance, and the behavioral sensitivity to the antimigraine agent, sumatriptan.Helping the world's coastal communities adapt to climate change impacts requires evaluating th
Gefällt mir
Kommentar
Teilen
